Sanj K. Patel - Sep 2, 2023 Form 4 Insider Report for Kiniksa Pharmaceuticals, Ltd. (KNSA)

Role
CHAIRMAN & CEO, Director
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
Stock symbol
KNSA
Transactions as of
Sep 2, 2023
Transactions value $
-$117,553
Form type
4
Date filed
9/6/2023, 07:06 PM
Previous filing
Apr 11, 2023
Next filing
Mar 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KNSA Class A Common Share Options Exercise +9.99K +23.47% 52.6K Sep 1, 2023 Direct F1
transaction KNSA Class A Common Share Tax liability -$78.7K -4.43K -8.43% $17.76 48.1K Sep 1, 2023 Direct
transaction KNSA Class A Common Share Options Exercise +6.57K +13.65% 54.7K Sep 2, 2023 Direct F1
transaction KNSA Class A Common Share Tax liability -$38.8K -2.19K -4% $17.76 52.5K Sep 2, 2023 Direct
holding KNSA Class A Common Share 83.3K Sep 2, 2023 Held by The Anglia 2013 Revocable Trust, u/d/t August 15, 2013
holding KNSA Class A Common Share 110K Sep 2, 2023 Held by The Marina 2016 Irrevocable Trust, u/d/t June 23, 2016

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KNSA Restricted Share Unit Options Exercise $0 -9.99K -25% $0.00 30K Sep 1, 2023 Class A Common Share 9.99K Direct F1, F2
transaction KNSA Restricted Share Unit Award $0 +25.9K $0.00 25.9K Sep 1, 2023 Class A Common Share 25.9K Direct F1, F3
transaction KNSA Share Option Award $0 +156K $0.00 156K Sep 1, 2023 Class A Common Share 156K $17.76 Direct F4
transaction KNSA Restricted Share Unit Options Exercise $0 -6.57K -33.33% $0.00 13.1K Sep 2, 2023 Class A Common Share 6.57K Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
F2 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 1, 2022.
F3 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 1, 2023.
F4 The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2023.
F5 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 2, 2021.